CRF Receptor 2 (CRF-R2) Neurons
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">CRF Receptor 2 Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Ligand</td>
<td>Affinity for CRF-R2</td>
</tr>
<tr>
<td class="label">Urocortin 2</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Urocortin 3</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Urocortin 1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">CRF</td>
<td>Low</td>
</tr>
<tr>
<td class="label">CRF (ovine)</td>
<td>Very Low</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Lateral Septum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Variable</td>
</tr>
</table>
Introduction
...CRF Receptor 2 (CRF-R2) Neurons
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">CRF Receptor 2 Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Ligand</td>
<td>Affinity for CRF-R2</td>
</tr>
<tr>
<td class="label">Urocortin 2</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Urocortin 3</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Urocortin 1</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">CRF</td>
<td>Low</td>
</tr>
<tr>
<td class="label">CRF (ovine)</td>
<td>Very Low</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Lateral Septum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Amygdala</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Brainstem</td>
<td>Variable</td>
</tr>
</table>
Introduction
Crf Receptor 2 Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Neurons expressing corticotropin releasing factor receptor 2 (CRF-R2), also known as CRHR2, represent a critical population in the stress response system. CRF-R2 is a G-protein coupled receptor that binds corticotropin releasing factor (CRF) and related peptides, particularly urocortin 2 and urocortin 3 [@lovenberg1995]. These neurons are predominantly located in brain regions involved in stress processing, emotional regulation, and autonomic control. The CRF-R2 system is distinct from CRF-R1 (CRF Receptor 1), which is more widely expressed and primarily mediates the endocrine stress response through the HPA axis.
<!-- multi-taxonomy-enrichment -->
Multi-Taxonomy Classification
Taxonomy Database Cross-References
Morphology & Electrophysiology
- Morphology: corticotropin-releasing neuron (source: Cell Ontology)
- Morphology can be inferred from Cell Ontology classification
External Database Links
- [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
- [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
- [CellxGene Census](https://cellxgene.cziscience.com/)
- [Human Cell Atlas](https://www.humancellatlas.org/)
Molecular Biology of CRF-R2
Gene and Protein Structure
The CRHR2 gene (encoding CRF-R2) is located on chromosome 7p14.3 in humans and encodes a 411-amino acid protein [@crhr]. The receptor structure includes:
- N-terminal extracellular domain: Binds CRF and urocortin peptides
- Seven transmembrane domains: Characteristic of GPCRs
- C-terminal intracellular domain: Couples to G proteins
Ligand Specificity
CRF-R2 has distinct ligand binding compared to CRF-R1:
Signaling Pathways
CRF-R2 activates multiple intracellular cascades:
cAMP/PKA pathway: Mediates stress response modulation
MAPK/ERK pathway: Affects neuronal survival
PI3K/Akt pathway: Neuroprotective effects
PLC/IP3 pathway: Calcium signaling modulationDistribution in the Nervous System
Brain Region Distribution
CRF-R2-expressing neurons are found in selective brain regions:
Cellular Expression
CRF-R2 is expressed in:
- Principal neurons: In hippocampus and cortex
- Interneurons: Modulating local circuits
- Astrocytes: Glial stress responses
Function in Normal Physiology
Stress Coping and Resilience
CRF-R2 neurons play a crucial role in stress resilience:
- Urocortin 2/3 signaling: Promotes stress adaptation
- Negative feedback: Modulates HPA axis activity
- Anxiety reduction: CRF-R2 activation has anxiolytic effects [@bale2004]
- Stress recovery: Facilitates return to homeostasis
Cardiovascular Regulation
In the brainstem and hypothalamus:
- Modulates heart rate and blood pressure
- Coordinates autonomic responses to stress
- May protect against heart failure
Appetite and Energy Balance
CRF-R2 in the hypothalamus:
- Reduces food intake (anorectic effects)
- Modulates energy expenditure
- May be targeted for obesity treatment
Memory and Learning
In the hippocampus:
- Modulates memory consolidation
- Affects emotional memory processing
- May protect against stress-induced memory impairment
Role in Neurodegenerative Diseases
Alzheimer's Disease
The CRF system, including CRF-R2, may be affected in Alzheimer's disease:
Dysregulation:
- Altered CRF levels in AD brains
- May affect neuronal survival
- Stress response system compromised
Therapeutic Potential:
- CRF-R2 agonists may provide neuroprotection
- Urocortin-based strategies under investigation [@pedersen2002]
Depression and Anxiety Disorders
CRF-R2 is a major target for mood disorder treatment:
Depression:
- CRF-R2 activation has antidepressant effects
- Reduced CRF-R2 in depression
- Under investigation for novel treatments
Anxiety:
- CRF-R2 mediates stress resilience
- Agonists reduce anxiety-like behavior
- Potential for anxiolytic drug development
Parkinson's Disease
CRF-R2 may play a role in Parkinson's disease:
- May modulate dopaminergic neuron function
- Possible therapeutic target
- Stress affects PD progression
Heart Failure
CRF-R2 is implicated in cardiovascular disease:
- Urocortin improves cardiac function
- CRF-R2 protects against heart failure
- Potential therapeutic application
Therapeutic Targeting
CRF-R2 Agonists
Urocortin Analogs:
- Urocortin 2: Selective CRF-R2 agonist
- Urocortin 3: Stress-adaptive peptide
- Synthetic analogs: In development
Clinical Applications:
- Depression treatment
- Heart failure
- Stress resilience
CRF-R2 Antagonists
Research Compounds:
- Antisauvagine-30: Selective CRF-R2 antagonist
- Astressin-R2B: Research tool
Potential Uses:
- Understanding CRF-R2 function
- Investigational tools
Clinical Development
- CRF-R2 agonists for depression
- Urocortin for heart failure
- Novel stress-targeted therapies
Genes and Proteins
- CRF Gene - Corticotropin Releasing Factor
- CRHR1 Gene - CRF Receptor 1
- Urocortin Genes - Urocortin 1, 2, 3
- Glucocorticoid Receptor
Cell Types
- Hippocampal Neurons
- Hypothalamic Neurons
- Amygdala Neurons
- Lateral Septum Neurons
Diseases
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- Depression
- Anxiety Disorders
- Heart Failure
Mechanisms
- Stress Responsemechanisms/stress-response-neurodegeneration)
- HPA Axis
- Synaptic Plasticity
- Corticotropin-Releasing Hormone (CRH/CRF) - The primary ligand for CRFR2
- CRF Receptor 1 (CRFR1) - Another CRF receptor subtype
- Urocortin (UCN) - Endogenous CRFR2 ligands
- Hypothalamic Neurons - CRFR2 expression in hypothalamus
- Amygdala Neurons - CRFR2 in stress circuitry
- Stress Responsemechanisms/stress-response-neurodegeneration) - CRFR2 in stress biology
- HPA Axis - Hypothalamic-pituitary-adrenal axis
External Links
- [CRHR2 Gene Database (GeneCards)](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRHR2)
- [CRHR2 Human Protein Atlas](https://www.proteinatlas.org/ENSG00000101327-CRHR2)
- [CRF Receptor Pharmacology Review](https://doi.org/10.1146/annurev.pharmtox.44.101802.121410)
- [UniProt: CRFR2 Human](https://www.uniprot.org/uniprot/Q00519)
- [IUPHAR/BPS Guide to Pharmacology: CRFR2](https://www.guidetopharmacology.org/GRAC/FamilyDisplayForward?familyId=45)
Background
The study of Crf Receptor 2 Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
bale2004, Bale, T.L., & Vale, W.W. (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annual Review of Pharmacology and Toxicology, 44, 525-557 (2004) [1](https://doi.org/10.1146/annurev.pharmtox.44.101802.121410)
crhr, CRHR2 Gene Card [1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRHR2)
lovenberg1995, (1995). Cloning and expression of a human CRF receptor (CRF-R2) from a lung carcinoma cell line. Biochemical and Biophysical Research Communications, 212(3), 812-818 (1995) [1](https://doi.org/10.1006/bbrc.1995.2033)
pedersen2002, (2002). Urocortin, a neuropeptide: novel therapies for neurodegenerative disorders. Current Opinion in Investigational Drugs, 3(5), 780-783 (2002)